Literature DB >> 15060884

Breast carcinoma with choriocarcinomatous features.

Erika Resetkova1, Aysegul Sahin, Alberto G Ayala, Nour Sneige.   

Abstract

Although breast carcinomas have been shown to produce various ectopic substances, including human chorionic gonadotropin, it is rare to identify morphologic differentiation compatible with the hormone produced by a tumor. Presently, only eight cases of breast carcinoma with focal choriocarcinomatous differentiation have been reported in the literature. This article describes the pathologic findings, immunohistochemical profile, and clinical course in two additional cases of this unusual variant of breast carcinoma. In the first case, the tumor had morphologic features suggestive of medullary carcinoma, and the patient is doing well 12 months after presentation. In the second case, the tumor was locally advanced at presentation with histologic features consistent with metaplastic carcinoma having squamous, sarcomatoid, and choriocarcinomatous elements. The patient presented with extensive multifocal metastases 6 months after the initial presentation and is not responding well to standard or experimental treatment regimen. Immunostaining for the beta subunit of human chorionic gonadotropin was localized mostly, but not entirely, to multinucleated syncytiotrophoblast-like giant cells within both tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060884     DOI: 10.1053/j.anndiagpath.2004.01.003

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  2 in total

1.  Breast carcinoma with choriocarcinomatous features: a case report.

Authors:  Hyun-Jung Sung; Young-In Maeng; Min-Kyung Kim; Sun-Jae Lee; Sung-Min Kang; Jin-Gu Bong; Hoon-Kyu Oh
Journal:  J Breast Cancer       Date:  2013-09-30       Impact factor: 3.588

Review 2.  Breast carcinoma with choriocarcinomatous features: a case report and review of the literature.

Authors:  Yanyun Zhu; Mei Liu; Jinyu Li; Fangfang Jing; Ruixia Linghu; Xiaoqin Guo; Shunchang Jiao; Junlan Yang
Journal:  World J Surg Oncol       Date:  2014-07-30       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.